Related Experiment Video
Updated: Oct 16, 2025

Determination of Tolerable Fatty Acids and Cholera Toxin Concentrations Using Human Intestinal Epithelial Cells and BALB/c Mouse Macrophages
Published on: May 30, 2013
Correlates of Protection for Cholera
Anita S Iyer1,2, Jason B Harris1,3
1Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Correlates of protection (CoPs) for cholera vaccines need robust associations with efficacy. Current vibriocidal antibodies are accepted but may not fully reflect protection mechanisms against Vibrio cholerae.
Area of Science:
- Immunology
- Vaccinology
- Microbiology
Background:
- A correlate of protection (CoP) measures immune response linked to protection from disease after vaccination or infection.
- The reliability of a CoP as a surrogate for vaccine efficacy hinges on the strength of its association with protection.
- For cholera, antitoxin responses to Vibrio cholerae are not linked to long-term immunity and are poor CoPs.
Purpose of the Study:
- To evaluate the suitability of correlates of protection (CoPs) for cholera vaccines.
- To determine if existing measures accurately reflect protective immunity against Vibrio cholerae.
- To assess the association between vibriocidal antibody titers and long-term cholera immunity.
Main Methods:
- Review of existing literature on cholera immunity and vaccine correlates.
- Analysis of the association between different immune responses (antitoxin, anti-O-polysaccharide, vibriocidal antibodies) and protection against Vibrio cholerae.
- Evaluation of vibriocidal antibodies as surrogate endpoints for cholera vaccine efficacy.
Main Results:
- Functional antibodies targeting the O-polysaccharide outer membrane of Vibrio cholerae, not antitoxin responses, appear crucial for protection.
- Vibriocidal antibodies are the most accepted CoP for cholera and are used as surrogate endpoints in some vaccine studies.
- The association between vibriocidal antibody titers and immunity is not absolute, suggesting they may not fully represent a mechanistic correlate of protection.
Conclusions:
- Protection against cholera is likely mediated by antibodies targeting the Vibrio cholerae O-polysaccharide.
- Vibriocidal antibodies, while accepted, may not be a perfect surrogate for cholera vaccine efficacy due to limitations in their association with immunity.
- Further research is needed to identify more robust mechanistic correlates of protection for cholera vaccines.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Correlation and Causation
Correlation versus Causation
If the dependent variable increases or decreases when the independent variable increases, there is a positive or negative...
Relative Risk
Hazard Ratio
For example, in a clinical trial...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Correlation
Two variables, for example, a and b, are said to be positively correlated if both variables move in the same direction. In other words, a positive correlation exists between two variables, a and b, if:

